Kalif Eliyahu Sharon bought TEVA
March 5, 2025 · Form 4 insider transaction
Kalif Eliyahu Sharon bought 79,664 shares of Teva Pharmaceutical Industries Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.; Restricted share units were granted on March 5, 2025, with 19,916 vesting on each of March 5, 2026, March 5, 2027, March 5, 2028 and March 5, 2029.; The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.